Drug cost guidelines putting a price on a patient s life, says blood-disorder group If a drug is clinically proven to drastically alter a patient’s quality of life and, in some cases, give them a life equal to that of a normal healthy person, what price do you put on that? asks Montrealer Barry Katsof.
Author of the article: Susan Schwartz • Montreal Gazette
Publishing date: Dec 16, 2020 • December 16, 2020 • 3 minute read • Audrey Lagacé, a nurse at Charles-Le Moyne Hospital, has taken an expensive medication to control a life-threatening blood disorder. She is concerned that plans for a national pharmacare program will mean clinical trials for diseases like hers will stop. Photo by John Mahoney /Montreal Gazette